Cargando…
Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours
CT-2584 HMS, 1-(11-dodecylamino-10-hydroxyundecyl)-3,7-dimethylxanthine-hydrogen methanesulphonate, is a modulator of intracellular phosphatidic acid. We treated 30 patients as part of a Phase I and pharmacokinetic study to determine the maximum-tolerated dose of CT-2584 HMS, toxicity profiles, phar...
Autores principales: | Cheeseman, S L, Brannan, M, McGown, A, Khan, P, Gardner, C, Gumbrell, L, Dickens, D, Ranson, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363467/ https://www.ncbi.nlm.nih.gov/pubmed/11104552 http://dx.doi.org/10.1054/bjoc.2000.1503 |
Ejemplares similares
-
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma
por: Blackhall, F H, et al.
Publicado: (2001) -
RcsAB is a major repressor of Yersinia biofilm development through directly acting on hmsCDE, hmsT, and hmsHFRS
por: Fang, Nan, et al.
Publicado: (2015) -
2584. Effects of Fecal Microbiota Transplantation for Decolonizing Multidrug-Resistant Organism
por: Seong, Hye, et al.
Publicado: (2019) -
Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro
por: Booth, C, et al.
Publicado: (1999) -
In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug
por: Grosios, K, et al.
Publicado: (1999)